Results 261 to 270 of about 43,753 (301)
Some of the next articles are maybe not open access.

MDSC: Markers, development, states, and unaddressed complexity

Immunity, 2021
Myeloid-derived suppressor cells (MDSCs) are one of the most discussed biological entities in immunology. While the context and classification of this group of cells has evolved, MDSCs most commonly describe cells arising during chronic inflammation, especially late-stage cancers, and are defined by their T cell immunosuppressive functions.
Samarth Hegde, Miriam Merad
exaly   +3 more sources

Targeting YTHDF2/MDSCs to improve radiotherapy

Cell Chemical Biology, 2023
Immunosuppression contributes to tumor-radiotherapy failure, but the mechanism remains elusive. Wang et al.1 reported that ionizing radiation (IR) induces YTHDF2 expression in myeloid-derived suppressor cells (MDSCs) via an IR-YTHDF2-NF-κB circuit, which contributes to MDSC expansion/migration and treatment failure. Genetic depletion or pharmacological
Xiaolan, Deng, Ying, Qing, Jianjun, Chen
openaire   +2 more sources

Signaling pathways involved in MDSC regulation [PDF]

open access: yesBiochimica Et Biophysica Acta: Reviews on Cancer, 2014
The immune system has evolved mechanisms to protect the host from the deleterious effects of inflammation. The generation of immune suppressive cells like myeloid derived suppressor cells (MDSCs) that can counteract T cell responses represents one such strategy.
William E Carson Iii
exaly   +3 more sources

MDSCs sneak CSCs out of (immuno)surveillance

Trends in Immunology, 2022
Cancer stem cells (CSCs) are known for their superior tumor-initiating and tumor-repopulating potential, partly reflecting their pronounced ability to evade immune recognition. Liu and colleagues recently identified a new aldehyde dehydrogenase (ALDH)-dependent mechanism whereby triple-negative breast CSCs evade immunosurveillance upon recruitment of ...
Carlos Jiménez-Cortegana   +2 more
openaire   +2 more sources

MDSC metabolite stuns T cells

Nature Reviews Immunology, 2020
A new study shows how myeloid-derived suppressor cells paralyse CD8+ T cell effector functions by transferring the metabolite methylglyoxal directly into the T cell cytosol, where it depletes essential amino acids.
openaire   +2 more sources

Monocytic MDSCs regulate macrophage-mediated xenogenic cytotoxicity

Transplant Immunology, 2015
Xenotransplantation is considered to be one of the most attractive strategies for overcoming the worldwide shortage of organs. However, many obstructions need to be overcome before it will achieve clinical use in patients. One such obstacle is the development of an effective immunosuppressive strategy.
Akira, Maeda   +10 more
openaire   +2 more sources

Tumor-related stress regulates functional plasticity of MDSCs

Cellular Immunology, 2021
Myeloid-derived suppressor cells (MDSCs) impair protective anti-tumor immunity and remain major obstacles that stymie the effectiveness of promising cancer therapies. Diverse tumor-derived stressors galvanize the differentiation, intra-tumoral expansion, and immunomodulatory function of MDSCs.
Jessica K. Mandula, Paulo C. Rodriguez
openaire   +2 more sources

Phenotypic Plasticity of MDSC in Cancers

Immunological Investigations, 2012
Myeloid-derived suppressor cells (MDSCs) were initially reported as suppressor of the adaptive immune responses against cancer and other diseases. However, emerging evidence suggest that MDSCs may also support anti-tumor immune responses under certain conditions or may inhibit tumor growth.
openaire   +2 more sources

Getting a hold on MDSCs

Science, 2020
Tumor Immunology Myeloid-derived suppressor cells (MDSCs) are immune cells that mediate immune suppression and are correlated with progressing cancer. How these cells arise and whether they can be therapeutically targeted akin to exhausted T cells are areas of active investigation. A persistent challenge in studying MDSCs has been the identification of
openaire   +1 more source

Home - About - Disclaimer - Privacy